Publication Name	World Journal of Hepatology
Manuscript ID	89860
Country	United Kingdom

Received	2023-11-15 10:20
Peer-Review Started	2023-11-15 10:22
To Make the First Decision
Return for Revision	2023-12-05 17:53
Revised	2023-12-12 17:10
Second Decision	2024-01-12 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-01-12 07:26
Articles in Press	2024-01-12 07:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-17 02:53
Publish the Manuscript Online	2024-02-27 11:58

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	New markers of fibrosis in hepatitis C: A step towards the Holy Grail?
Manuscript Source	Invited Manuscript
All Author List	Konstantinos John Dabos
ORCID	Author(s) ORCID Number Konstantinos John Dabos http://orcid.org/0000-0002-5082-0344
Funding Agency and Grant Number
Corresponding Author	Konstantinos John Dabos, MD, PhD, Doctor, Doctor, Department of Hepatology, St Hohn's hospital , Livingston, Scotland . UK, Howden Road West, Livingston EH54 6PP, West lothian, United Kingdom. konstantinos.dabos@nhslothian.scot.nhs.uk
Key Words	Hepatitis C metabolomics; Fibrosis; Non invasive markers; Metavir
Core Tip	A novel approach for identifying non-invasive biomarkers as a step towards an accurate serological tool for fibrosis staging in hepatitis C.
Publish Date	2024-02-27 11:58
Citation	Dabos KJ. New markers of fibrosis in hepatitis C: A step towards the Holy Grail? World J Hepatol 2024; 16(2): 112-114
URL	https://www.wjgnet.com/1948-5182/full/v16/i2/112.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i2.112

Full Article (PDF)	WJH-16-112-with-cover.pdf
Full Article (Word)	WJH-16-112.docx
Manuscript File	89860_Auto_Edited-LJH-YJP.docx
Answering Reviewers	89860-Answering reviewers.pdf
Audio Core Tip	89860-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89860-Conflict-of-interest statement.pdf
Copyright License Agreement	89860-Copyright license agreement.pdf
Peer-review Report	89860-Peer-review(s).pdf
Scientific Misconduct Check	89860-Bing-Liu JH-2.png
Scientific Misconduct Check	89860-CrossCheck.png
Scientific Editor Work List	89860-Scientific editor work list.pdf
CrossCheck Report	89860-CrossCheck report.pdf